将移动健康创新融入去中心化瘤学试验中
Fatma Nur Cicin1, Irfan Cicin2
1Faculty of Economics, Administrative and Social Sciences, Department of Management Information Systems, Istinye University, Istanbul, Türkiye, Turkey.
Journal of medical systems
|August 8, 2025
概括
分散临床试验 (DCT) 中的移动健康 (mHealth) 技术为瘤学研究提供了创新的解决方案. 这些工具增强了患者监测,参与和数据收集,旨在实现更公平,更有效的癌症试验.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 临床试验创新 临床试验创新
背景情况:
- 分散临床试验 (DCT) 在设计和执行方面面临挑战.
- 移动健康 (mHealth) 技术为这些挑战提供了潜在的解决方案.
- 瘤学研究可以从将mHealth整合到DCT中受益.
研究的目的:
- 探索mHealth技术在瘤学中的DCT中的变革性作用.
- 审查将移动健康纳入瘤学DCT的潜在好处和挑战.
主要方法:
- 这是一个叙事评论.
- 该综述综合了关于mHealth技术和DCT在瘤学的当前文献.
主要成果:
- 移动健康工具 (可穿戴设备,远程医疗,人工智能) 实现实时监控,远程数据收集和改善参与者的参与.
- 潜在的好处包括增强招聘,治疗坚持,公平获取和个性化瘤学.
- 挑战包括监管障碍,数据隐私和技术差异.
结论:
- 在DCT中整合mHealth可以将瘤学研究转向以患者为中心,数据驱动的范式.
- 应对挑战对于广泛采用和加速药物开发至关重要.
- 人工智能和区块链的未来进展可能会进一步增强DCT.
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
8.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.3K
Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


